In:
Romanian Journal of Psychiatry and Psychotherapy, AMALTEA Medical Publishing House, Vol. 18, No. 1 ( 2016-03-31), p. 15-20
Abstract:
Background: Depression is a common and disabling psychiatric condition which cause substantial impairment in daily functioning and increases the risk for both social and physical disability, and as a result, increases the costs for other medical services. Objectives: The study aims at underlining particularities regarding the evolution and functionality of patients with major depressive disorder (MDD) under Agomelatine treatment. The most important objectives were to evaluate the daily functionality in MDD patients under treatment, the evolution of the symptomatology and treatment adherence. Methods: We included in a prospective, observational and longitudinal study 1194 patients with depressive episode, who were assessed with Clinical Global Impressions Scale (CGI scale) and Quick Inventory of Depressive Symptomatology Scale (QUIDS-C16), in order to perform a correlational analysis. Results: In this study, the target group had a moderate symptomatology (depressed mood, loss of concentration, anhedonia) and had a good evolution from the second week of treatment and a considerable improvement of anhedonia after 10 weeks of treatment. Conclusions: The antidepressant treatment with Agomelatine was considered efficient and safe, with an important improvement of the symptomatology after 10 weeks of treatment, a good treatment adherence and improvement in daily functioning.
Type of Medium:
Online Resource
ISSN:
2972-1954
,
2972-1962
DOI:
10.37897/RJPP.2016.1
DOI:
10.37897/RJPP.2016.1.5
Language:
Unknown
Publisher:
AMALTEA Medical Publishing House
Publication Date:
2016
Permalink